Diagnostic Value of MRI Compared to Histopathological Results in Differentiating Benign from Malignant Ovarian Masses

Introduction and aim: Ovarian cancer is a prevalent neoplastic condition among females. Early diagnosis is essential in improving patient outcomes. This study aimed to determine the diagnostic value of magnetic resonance imaging (MRI) compared to histopathological diagnosis to distinguish between benign and malignant ovarian masses.Methods: The present cross-sectional study, which was conducted between 2021 and 2022, included a cohort of women with ovarian mass.Gyneco-oncologists referred all patients to the MRI center.The imaging protocol encompassed T1 and T2 weighted images, T1 fat-suppressed sequence, post-contrast and diffusion-weighted images (DWI).After surgery, the histopathological results were compared to the MRI diagnosis.Statistical analysis was done by using SPSS v.25 software.Results: A total of 67 women aged 15-82 years old were included in this study.Compared to histopathological diagnosis, MRI had a sensitivity of 96%, a specificity of 69%, a positive predictive value of 64.9% and a negative predictive value of 96.7%.Among patients under 40 years old, MRI showed a sensitivity of 100%, a specificity of 76.2%, a positive predictive value of 72.2% and a negative predictive value of 100%.Solid component and contrast enhancement within the solid component was significantly more frequent in patients with malignant diagnoses than those with benign masses (p<0.05). Conclusion:According to the results of the study, MRI is valuable for discriminating between benign and malignant ovarian masses, especially in patients under 40.